IHS Chemical Week

World News and Views :: Projects

Lonza to Build Cell Therapy Production Facility in Singapore

10:23 AM MDT | May 22, 2009 | DEEPTI RAMESH

Lonza says it will build a cell therapy facility in Singapore to expand its global presence and meet growing worldwide demand. Lonza will invest SF30 million ($27 million) in the first construction phase of the plant, which will be located adjacent to Lonza’s large-scale mammalian cell culture facility at Tuas Biomedical Park. Construction is expected to begin in early 2010, with start up of two suites by mid-2011. Borgas: Cell therapy to become important innovation driver. The facility will be designed to accommodate additional suites to meet...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa